Prothrombin 20210A Mutation
Authors:
- Ivan BankIBIvan Bank
- Eduard J. LibourelELEduard J. Libourel
- Saskia MiddeldorpSMSaskia Middeldorp
- Elisabeth C. M. van PampusEPElisabeth C. M. van Pampus
- Maria M. W. KoopmanMKMaria M. W. Koopman
- Karly HamulyákKHKarly Hamulyák
- Martin H. PrinsMPMartin H. Prins
- Jan van der MeerJMJan van der Meer
- Harry R. BüllerHBHarry R. Büller
Open Access
- 27 September 2004
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (17) , 1932-1937
Abstract
Since its identification as a risk factor for venous thromboembolism (VTE) in 1996, there is growing interest in the prothrombin 20210A mutation and its role in cardiovascular and pregnancy-related diseases.1 However, there are some unresolved issues.Keywords
This publication has 2 references indexed in Scilit:
- Can screening for genetic markers improve peripheral artery bypass patency?Journal of Vascular Surgery, 2002
- Prothrombin 20210 G→A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 2000